The Eurasian Pharmaceutical Register: An Instrument for Pharmaceutical Companies By Mrs. Aurelia Ceban
The Eurasian Pharmaceutical Register, established and maintained by the Eurasian Patent Office (EAPO), is a comprehensive information resource that consolidates data on patent rights for active pharmaceutical ingredients (API). This tool is essential for pharmaceutical companies operating in the eight Eurasian Patent Convention (EAPC) Contracting States. In this article, Mrs. Aurelia Ceban, Deputy Director of the Examination Department and Head of the Chemistry and Medicines Division at the Eurasian Patent Office, discusses how the register supports patent enforcement and provides reliable, up-to-date information to stakeholders.
The Eurasian Pharmaceutical Register offers free public access to detailed information about patents related to APIs, including chemical compounds, biotechnological products, production processes, and new combinations or medical uses. By allowing searches based on International Nonproprietary Names (INN), patent numbers, and patent holders, the register ensures that pharmaceutical companies can easily track the legal status of patents across the EAPC Contracting States.
The inclusion of patents in the Pharmaceutical Register undergoes a thorough examination by EAPO experts, guaranteeing the accuracy and reliability of the information. This resource is highly valued by patent owners, as it provides a certified tool for enforcing patent rights across multiple jurisdictions. With its ability to offer official recognition of patent information, the register plays a critical role in the protection and commercialization of pharmaceutical innovations.
As of April 2024, the register contains data on 359 Eurasian and national patents linked to 235 INNs and their combinations. The EAPO has further enhanced the register’s utility by introducing new regulations that allow for the recognition of the information as official, enabling its use in legal and enforcement proceedings within the EAPC Contracting States. This development ensures that pharmaceutical companies have the legal backing needed to protect their intellectual property effectively.
Conclusion
The Eurasian Pharmaceutical Register is an indispensable tool for pharmaceutical companies looking to safeguard their API-related patents. By providing comprehensive, reliable, and publicly accessible information, the register supports the enforcement of patent rights and facilitates the smooth introduction of medicines into the market across the Eurasian region.
Please read the full article by Mrs. Aurelia Ceban in Our Latest Edition of The Global IP Matrix Magazine
You can now access the article and the complete edition of the Global IP Matrix magazine by listening here.
Comentarios